Non–AIDS-Defining Cancers

  • Authors: David Aboulafia, MD; Liron Pantanowitz, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 12/12/16 (What's New)

Summary

  • Challenges to management of NADCs:
    • Reactive lymphadenopathy or other HIV-related imaging abnormalities can interfere with tumor staging[Bhargava 2008; Warwick 2011]
    • HIV-related comorbidities may result in poor performance status, which can affect response to treatment

Action required